Serum S100A12 levels were also slightly lower in patients with SLE who tested positive for anti-dsDNA antibodies (p<0.05) and in patients with low serum complement C3 and/or C4 (p<0.01) when compared with individuals without these laboratory anomalies. Here, S100A12 is linked to systemic lupus erythematosus.